mifepristone has been researched along with Multiple Myeloma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, ME; Bissonnette, RP; Cuervo, C; Gharbaoui, CJ; Higuchi, RI; Hudson, AR; Kallel, EA; Lamph, WW; Li, Y; Mais, DE; Marschke, KB; Miner, JN; Negro-Vilar, A; Phillips, DP; Roach, SL; Rungta, D; Valdez, LJ; Vassar, A; Yen, J; Zhi, L | 1 |
| Allen, V; Blackaby, W; Chan, GKY; Chang, JH; Chiang, PC; Del Rosario, G; Diène, C; Do, S; Drummond, J; Ebens, AJ; Fan, E; Harstad, EB; Hodges, A; Hu, H; Jia, W; Kofie, W; Kolesnikov, A; Ly, J; Lyssikatos, JP; Matteucci, M; Moffat, JG; Munugalavadla, V; Murray, J; Nash, D; Noland, CL; Ross, L; Rouse, C; Sharpe, A; Slaga, D; Sun, M; Tsui, V; Wallweber, H; Wang, X; Yu, SF | 1 |
| Bali, M; Gandhi, S; Li, Z; Masih-Khan, E; Pollett, JB; Stewart, AK; Wen, XY; Zhu, YX | 1 |
| Fryknäs, M; Gustafsson, MG; Haglund, C; Isaksson, A; Larsson, R; Lövborg, H; Nygren, P; Rickardson, L | 1 |
| Leikin, R; Moalli, PA; Pillay, S; Rosen, ST; Weiner, D | 1 |
5 other study(ies) available for mifepristone and Multiple Myeloma
| Article | Year |
|---|---|
Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myeloma.
Topics: Animals; Antineoplastic Agents; Benzopyrans; Binding, Competitive; Dexamethasone; Humans; Mice; Mineralocorticoid Receptor Antagonists; Models, Molecular; Multiple Myeloma; Quinolines; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Stereoisomerism; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2007 |
Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple Myeloma.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dogs; Female; Humans; Macaca fascicularis; Madin Darby Canine Kidney Cells; Male; Mice, SCID; Molecular Structure; Multiple Myeloma; Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Pyrazoles; Rats, Sprague-Dawley; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2019 |
RU486-inducible retrovirus-mediated caspase-3 overexpression is cytotoxic to bcl-xL-expressing myeloma cells in vitro and in vivo.
Topics: Animals; Apoptosis; bcl-X Protein; Caspase 3; Caspases; Cell Line, Tumor; Enzyme Induction; Genetic Therapy; Genetic Vectors; Humans; Mice; Mifepristone; Multiple Myeloma; Neoplasms, Experimental; NIH 3T3 Cells; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-bcl-2; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Fibroblast Growth Factor; Retroviridae; Survival Rate; Time Factors | 2003 |
Screening of an annotated compound library for drug activity in a resistant myeloma cell line.
Topics: Antineoplastic Agents; Betamethasone; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Glucocorticoids; Humans; Inhibitory Concentration 50; Mifepristone; Multiple Myeloma; Oligonucleotide Array Sequence Analysis; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2006 |
A mechanism of resistance to glucocorticoids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNA.
Topics: Adult; Blotting, Southern; Cell Survival; Dexamethasone; Drug Resistance; Female; Gene Expression; Glucocorticoids; Humans; Mifepristone; Multiple Myeloma; Phenotype; Receptors, Glucocorticoid; RNA, Messenger; Tumor Cells, Cultured | 1992 |